NEW YORK, Jan 24 An influential consumer advocacy group is pressing Pfizer Inc to supply more of its new Covid-19 pill Paxlovid to developing countries this year, concerned that access to the treatment will mirror inequalities in vaccines. Public Citizen sent a letter to Pfizer Chief Executive.
By Michael Erman NEW YORK (Reuters) - An influential consumer advocacy group is pressing Pfizer Inc to supply more of its new COVID-19 pill Paxlovid t.